Breaking News, Collaborations & Alliances

Asahi Kasei Pharma Contracts ProBioGen

Will use ProBioGen’s technologies for the advancement of its biologics pipeline.

By: Contract Pharma

Contract Pharma Staff

ProBioGen AG has closed a master service agreement with Asahi Kasei Pharma. As a CDMO in high-tier cell line development till large scale GMP manufacturing, ProBioGen will use its proprietary technologies, like the CHO.RiGHT cell line development platform and DirectedLuck transposase technology, to enable Asahi Kasei Pharma to advance their biologics pipeline.   “We are enchanted to work with Asahi Kasei Pharma on one of their key projects and are convinced that we can make a difference by apply...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters